English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/147473
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Crystal structure of glyceraldehyde-3-phosphate dehydrogenase from the gram-positive bacterial pathogen A. vaginae, an immunoevasive factor that interacts with the human C5a anaphylatoxin

AuthorsQuerol-García, Javier; Fernández, Francisco J. ; Gómez, Sara; Melchor-Tafur, Cecilia; Franco, Virginia; Rodríguez de Córdoba, Santiago ; Vega, María Cristina
Complement system
GAPDH (Glyceraldehyde-3-phosphate Dehydrogenase)
Gram-positive pathogen
X-ray crystallography
Issue Date14-Mar-2017
PublisherFrontiers Media
CitationFrontiers in Microbiology (2017) Querol-García, Javier et al.
AbstractThe Gram-positive anaerobic human pathogenic bacterium Atopobium vaginae causes most of the cases of bacterial vaginosis and opportunistic infections in immunocompromised patients. In addition to its well-established role in carbohydrate metabolism, D-glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from Streptococcus pyogenes and S. pneumoniae have been reported to act as an extracellular virulence factor during streptococcal infections. Here, we report the crystal structure of GAPDH from A. vaginae (AvGAPDH) at 2.19 Å resolution. The refined model has a crystallographic Rfree of 22.6%. AvGAPDH is a homotetramer wherein each subunit is bound to a nicotinamide adenine dinucleotide (NAD+) molecule. The AvGAPDH enzyme fulfills essential glycolytic as well as moonlight (non-glycolytic) functions, both of which might be targets of chemotherapeutic intervention. We report that AvGAPDH interacts in vitro with the human C5a anaphylatoxin and inhibits C5a-specific neutrophil chemotaxis, thereby suggesting the participation of AvGAPDH in complement-targeted immunoevasion in a context of infection. The availability of high-quality structures of AvGAPDH and other homologous virulence factors from Gram-positive pathogens is critical for drug discovery programs. In this study, sequence and structural differences between AvGAPDH and related bacterial and eukaryotic GAPDH enzymes are reported in an effort to understand how to subvert the immunoevasive properties of GAPDH and evaluate the potential of AvGAPDH as a druggable target.
Publisher version (URL)https://doi.org/10.3389/fmicb.2017.00541
Appears in Collections:(CIB) Artículos
Files in This Item:
File Description SizeFormat 
fmicb-Vega 2017.pdf4,35 MBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.